Outlook on the Ophthalmic Drug Delivery System Global Market to 2031 – Emerging Novel Ocular Drug Delivery Systems are Driving Growth – QNT Press Release

[ad_1]

DUBLIN, Aug. 11, 2022 /PRNewswire/ — The “Global Ophthalmic Drug Delivery System Market 2021-2031 by Product, Dosage Form, Disease, Setting, and Region: Trend Forecast and Growth Opportunity” report has been added to ResearchAndMarkets.com’s offering.

The global ophthalmic drug delivery system market will reach $30,013.7 million by 2031, growing by 6.9% annually over 2021-2031, driven by the growing prevalence of ophthalmic diseases, the emerging novel ocular drug delivery systems, rise in number of ophthalmic procedures that require attentive post procedural care, and the increasing demand to deliver controlled dosage forms for pediatric and geriatric population.

This report is based on a comprehensive research of the entire global ophthalmic drug delivery system market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year.

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces

The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and RussiaUkraine conflict. The balanced (most likely) projection is used to quantify global ophthalmic drug delivery system market in every aspect of the classification from perspectives of Product, Dosage Form, Disease, Setting, and Region.

Based on Product, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Pre-filled Syringes
  • Multidose Eyedroppers
  • Squeeze Dispensers
  • Mist Sprayers
  • Contact Lenses
  • Ocular Inserts
  • Intraocular Implants
  • Punctal Plugs
  • Other Products

Based on Dosage Form, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Solutions
  • Gels
  • Ointments
  • Suspensions
  • Emulsions
  • Liposomes & Nanoparticles

By Disease, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Glaucoma
  • Diabetic Retinopathy
  • Cataract
  • Dry Eye Syndrome
  • Macular Degeneration
  • Diabetic Macular Edema
  • Refractive Issues
  • Other Diseases

By…

Full story available on Benzinga.com

[ad_2]

Source link